Effect of Transjugular Intrahepatic Portosystemic Shunt on Thrombocytopenia Associated with Cirrhosis

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 2000 Dec 16

PMID 11117569

Citations 10

Authors

Z Karasu

A Gurakar

B Kerwin

S Hulagu

A Jazzar

R McFadden

B Nour

A Sebastian

F Cassidy

K Stokes

D H Van Thiel

H Wright

Affiliations

Soon will be listed here.

Abstract

Thrombocytopenia is a frequent complication of cirrhosis. Its pathogenesis is not well known, but it has been suggested that splenic congestion induced by portal hypertension may be a major contributory factor. However, the available data regarding the effect of portal decompression either by surgical shunts or transjugular intrahepatic portosystemic shunt (TIPS) on peripheral platelet count in cirrhotics is conflicting. We studied the effects of TIPS on platelet count and mean platelet volume, following a successful TIPS placement. The platelet count had a tendency to decrease but was not statistically significant (120,100 +/- 72,100/mm3 before TIPS vs 99,800 +/- 51,400/mm3 after TIPS). The mean platelet volume remained essentially unchanged (9.8 +/- 1.5 fL before TIPS and 9.9 +/- 1.5 fL after TIPS). These results confirm that TIPS has an unpredictable effect on platelet count in cirrhotic patients with thrombocytopenia. The lack of a consistent increase in the peripheral mean platelet volume following TIPS placement suggests that TIPS is unable to significantly enhance the release of platelets sequestered in the splenic compartment in portal hypertension.

Citing Articles

Change in Platelet Count after Transjugular Intrahepatic Portosystemic Shunt Creation: An Advancing Liver Therapeutic Approaches (ALTA) Group Study.

Wong R, Ge J, Boike J, German M, Morelli G, Spengler E J Vasc Interv Radiol. 2023; 34(8):1364-1371.

PMID: 37100199 PMC: 10998695. DOI: 10.1016/j.jvir.2023.04.015.

Prediction of Patient Survival with Psoas Muscle Density Following Transjugular Intrahepatic Portosystemic Shunts: A Retrospective Cohort Study.

Zhang B, Cai W, Gao F, Lin X, Qian T, Gu K Med Sci Monit. 2022; 28:e934057.

PMID: 35031594 PMC: 8767767. DOI: 10.12659/MSM.934057.

Thrombocytopenia in Chronic Liver Disease: Challenges and Treatment Strategies.

Desai S, Subramanian A Cureus. 2021; 13(7):e16342.

PMID: 34277309 PMC: 8276329. DOI: 10.7759/cureus.16342.

Efficacy and safety of laparoscopic splenectomy for hypersplenism secondary to portal hypertension after transjugular intrahepatic portosystemic shunt.

Li Y, Liu Z, Liu C BMC Gastroenterol. 2021; 21(1):61.

PMID: 33573590 PMC: 7879518. DOI: 10.1186/s12876-021-01647-2.

Incidence of portal vein thrombosis after splenectomy and its influence on transjugular intrahepatic portosystemic shunt stent patency.

Dong F, Luo S, Zheng L, Chu J, Huang H, Zhang X World J Clin Cases. 2019; 7(17):2450-2462.

PMID: 31559281 PMC: 6745325. DOI: 10.12998/wjcc.v7.i17.2450.

References

Shulman N, Watkins Jr S, ITSCOITZ S, Students A . Evidence that the spleen retains the youngest and hemostatically most effective platelets. Trans Assoc Am Physicians. 1968; 81:302-13. View

Stiegler G, Stohlawetz P, Peck-Radosavljevic M, Jilma B, Pidlich J, Wichlas M . Direct evidence for an increase in thrombopoiesis after liver transplantation. Eur J Clin Invest. 1998; 28(9):755-9. DOI: 10.1046/j.1365-2362.1998.00348.x. View

Puttini M, Marni A, Montes F, Belli L . Effect of portasystemic shunt on hypersplenism: clinical study in 129 patients with cirrhosis. Am Surg. 1979; 45(7):444-8. View

Hutchison D, Genton E, Porter K, Daloze P, Huguet C, BRETTSCHNEIDER L . Platelet changes following clinical and experimental hepatic homotransplantation. Arch Surg. 1968; 97(1):27-33. PMC: 2975382. DOI: 10.1001/archsurg.1968.01340010057003. View

Mutchnick M, Lerner E, CONN H . Effect of portacaval anastomosis on hypersplenism. Dig Dis Sci. 1980; 25(12):929-38. DOI: 10.1007/BF01308044. View

Thompson C, Eaton K, Princiotta S, Rushin C, Valeri C . Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol. 1982; 50(3):509-19. DOI: 10.1111/j.1365-2141.1982.tb01947.x. View

Lawrence S, Lezotte D, Durham J, Kumpe D, Everson G, Bilir B . Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS). A retrospective analysis. Dig Dis Sci. 1995; 40(7):1575-80. DOI: 10.1007/BF02285211. View

Malt R . Portasystemic venous shunts (first of two parts). N Engl J Med. 1976; 295(1):24-9. DOI: 10.1056/NEJM197607012950106. View

Martin 3rd T, Somberg K, Meng Y, Cohen R, Heid C, de Sauvage F . Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med. 1997; 127(4):285-8. DOI: 10.7326/0003-4819-127-4-199708150-00005. View

10.

Laufer N, Freund H, Charuzi I, Grover N . The influence fo traumatic splenectomy on the volume of human platelets. Surg Gynecol Obstet. 1978; 146(6):889-92. View

11.

Alvarez O, Lopera G, Patel V, Encarnacion C, Palmaz J, Lee M . Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients. Am J Gastroenterol. 1996; 91(1):134-7. View

12.

Macpherson A, Innes J . Peripheral blood picture after operation for portal hypertension. Lancet. 1953; 1(6771):1120-3. DOI: 10.1016/s0140-6736(53)92308-3. View

13.

Ferrara J, Ellison E, Martin Jr E, Cooperman M . Correction of hypersplenism following distal splenorenal shunt. Surgery. 1979; 86(4):570-3. View

14.

Wadenvik H, Denfors I, Kutti J . Splenic blood flow and intrasplenic platelet kinetics in relation to spleen volume. Br J Haematol. 1987; 67(2):181-5. DOI: 10.1111/j.1365-2141.1987.tb02324.x. View

15.

Marni A, Trojsi C, Belli L . Distal splenorenal shunt. Hemodynamic advantage over total shunt and influence on clinical status, hepatic function and hypersplenism. Am J Surg. 1981; 142(3):372-6. DOI: 10.1016/0002-9610(81)90352-4. View

16.

VANG J, Simert G, Hansson J, Thylen U, Bengmark T . Results of a modified distal spleno-renal shunt for portal hypertension. Ann Surg. 1977; 185(2):224-8. PMC: 1396101. DOI: 10.1097/00000658-197702000-00016. View

17.

Hutson D, Zeppa R, Levi J, Schiff E, Livingstone A, Fink P . The effect of the distal splenorenal shunt on hypersplenism. Ann Surg. 1977; 185(5):605-12. PMC: 1396162. DOI: 10.1097/00000658-197705000-00014. View

18.

Bowdler A . Splenomegaly and hypersplenism. Clin Haematol. 1983; 12(2):467-88. View

19.

Sungaran R, Markovic B, Chong B . Localization and regulation of thrombopoietin mRNa expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood. 1997; 89(1):101-7. View

20.

CONN H . Transjugular intrahepatic portal-systemic shunts: the state of the art. Hepatology. 1993; 17(1):148-58. View